GlaxoSmithKline Pharmaceuticals Limited (BOM: 500660)

GlaxoSmithKline Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 13, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	416,180	329,173	224,319	281,714	244,012	210,953
Market Cap Growth	78.36%	46.74%	-20.37%	15.45%	15.67%	-4.20%
Enterprise Value	395,219	313,334	211,499	270,099	237,483	201,694
Last Close Price	2456.70	1910.37	1272.88	1505.45	1279.15	1077.26
PE Ratio	61.66	54.86	35.31	15.05	60.50	195.80
Forward PE	45.33	44.16	35.58	42.30	40.93	39.19
PS Ratio	11.69	9.53	6.90	8.59	8.34	6.54
PB Ratio	25.28	18.52	12.88	10.58	16.51	11.59
P/TBV Ratio	28.21	18.77	13.14	10.72	17.01	11.91
P/FCF Ratio	44.27	59.76	50.96	36.30	45.72	63.05
P/OCF Ratio	48.05	56.56	46.33	34.75	42.22	43.01
PEG Ratio	3.50	3.50	3.50	3.50	3.50	3.50
EV/Sales Ratio	11.10	9.07	6.50	8.24	8.12	6.26
EV/EBITDA Ratio	38.86	35.58	26.83	36.36	41.42	31.37
EV/EBIT Ratio	41.21	37.35	28.26	38.65	45.71	34.36
EV/FCF Ratio	42.04	56.89	48.05	34.80	44.50	60.28
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.02	0.02
Debt / EBITDA Ratio	0.01	0.02	0.02	0.03	0.06	0.06
Debt / FCF Ratio	0.02	0.03	0.04	0.03	0.06	0.13
Asset Turnover	1.01	1.00	0.82	0.85	0.94	0.92
Inventory Turnover	2.62	2.75	2.62	2.55	2.49	2.73
Quick Ratio	1.31	1.45	1.50	1.83	1.02	1.17
Current Ratio	1.66	1.84	1.88	2.18	1.63	1.74
Return on Equity (ROE)	42.03%	33.53%	27.59%	18.39%	17.42%	4.71%
Return on Assets (ROA)	17.09%	15.24%	11.75%	11.27%	10.40%	10.41%
Return on Capital (ROIC)	36.91%	29.52%	21.07%	20.82%	19.24%	18.33%
Earnings Yield	1.62%	1.79%	2.72%	6.02%	1.47%	0.44%
FCF Yield	2.26%	1.67%	1.96%	2.75%	2.19%	1.59%
Dividend Yield	1.30%	1.68%	2.51%	1.99%	2.35%	1.86%
Payout Ratio	80.23%	91.80%	249.80%	29.89%	189.04%	363.51%
Total Shareholder Return	3.19%	1.68%	2.51%	1.99%	2.35%	1.86%

Source: S&P Capital IQ. Standard template. Financial Sources.